Skip to content
BALCAO · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

Electromedical Technologies, Inc. EMED

5 fiscal years on record · USD · FY2023 reported · SEC filings only
$1.3M
▲ 17.3% YoY
$-2.6M
$-1.6M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Electromedical Technologies is a bioelectronics manufacturing and marketing company. We offer U.S. Food and Drug Administration (FDA) cleared medical devices for pain management. Our mission is to improve global wellness for people suffering from various painful conditions by relieving chronic and acute pain using energy, frequency, and vibration as an alternative to pharmaceuticals and that one day, read and modify electrical signals passing along nerves in the body, to restore long-term health. We engineer simple-to-use bioelectronics therapy devices, which send a proprietary sequence of electrical signals. The Company is publicly traded on the OTC Markets under the symbol EMED.

Written from the business description in Electromedical Technologies, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 1 May 2024. Every sentence was checked against that document before publication.

Growth

USD 1.3M
Revenue, FY2023 · full 5-year series below
Revenue $M Net income $M
FY2023 · Revenue 1.3 · Net income -2.6
0.5M1.0M-3.0M-6.0M
201920222023
Compound annual growth
+22.3%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−196 cents
lost on every revenue dollar
Operating margin Net margin
FY2023 · Operating -153.1% · Net -195.8%
-500%
201920212023
ROE

Not applicable: equity was zero or negative in this period, so return on equity has no meaning.

Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2023 · dividends + net buybacks

Total assetsUSD 748,383.00
EquityUSD -2.9M
CashUSD 87,704.00
Gross debtUSD 150,000.00
Net debtUSD 62,296.00
Current ratio0.13×

Equity was zero or negative — liabilities equaled or exceeded assets. No ratio is shown.

The 5-year record

5 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
EMED, 5-year financial record
Metric 20232022202120202019
Revenue $B0.00.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0
Income tax $B◌◌◌◌◌
Net income $B−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0◌◌◌◌
EPS, diluted $0.00−0.03−0.24−0.20−0.10
Dividend / sh $◌◌◌◌◌
Payout % — not applicable: no dividend—————
ROE % — not applicable: negative equity—————
Shares out B0.460.190.090.030.02

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 24 reconciliationsAUDITED

Reconciled in 5 of the 5 fiscal years we could check. 24 checks were skipped: the balance sheet is not tagged before 2019. 12 checks were skipped: EPS is not tagged before 2019. 12 checks were skipped: revenue is not tagged before 2019.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company, smaller reporting company
Data on record since2019

Share this section

Download image